—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
风湿病学和免疫学研究(英文)(Rheumatology and Immunology Research)(国际刊号)(OA期刊)
国际号刊 - 季刊
  • 风湿病学和免疫学研究(英文)(Rheumatology and Immunology Research)(国际刊号)(OA期刊)
  • 复合影响因子:0
  • 知网外文库,维普目次
  •  
  投稿方式:官网投稿
  • 栏目频次
  • 一作占比
  • 单位占比
  • 热词

高频栏目

100%期平均发文量2篇
100%期平均发文量1篇
100%期平均发文量1篇
100%期平均发文量1篇
100%期平均发文量1篇

中频栏目

50.0%期平均发文量1篇
50.0%期平均发文量1篇
50.0%期平均发文量1篇
暂无一作信息.
暂无单位信息.
暂无关键词信息.
  • 更多

    期刊简介

  • 《风湿病学和免疫学研究(英文)》(Rheumatology and Immunology Research)(季刊),创刊于2020年,由国家皮肤与免疫疾病临床医学研究中心主办。作为 “国家皮肤与免疫疾病临床研究中心”的官方杂志,RIR将为中国的风湿病与免疫疾病学者在国际舞台上发出中国的声音、为广大中国风湿病与免疫病学者搭建一个展示研究成果的平台,将成为扩大“国家皮肤与免疫疾病临床医学研究中心”的国内与国际影响、促进我国风湿病学者与免疫病学家掌握国际风湿病学与免疫学前沿与动态、聚焦学科发展、展现领域发展趋势,助力中国风湿病与免疫学家走向世界,提高全球影响力的重要载体。

  • 基本信息

  • 期刊名称:风湿病学和免疫学研究(英文)(Rheumatology and Immunology Research)(国际刊号)(OA期刊)
  • 主管单位:
  • 主办单位:国家皮肤与免疫疾病临床医学研究中心
  • 国内刊号:无CN刊号
  • 国际刊号:ISSN 2719-4523
  • 出刊日期:
    期刊定价:
  • 邮发代码:
  • 所在省区:北京
    邮政编码:
  • 联系地址:

  • 投稿信息

  • 学科分类:基础医学
    版面费用:待核实
  • 字数要求:0
    查重要求:-
  • 复合因子:0
    综合因子:0
  • 审  稿 费:待核实
    稿费:待核实
  • 本刊可发:
  • 特殊属性:外文期刊

  • 联系方式

  • 投稿网址:http://www.editorialmanager.com/rir/
  • 官网网址:https://www.degruyterbrill.com/journal/key/rir/html
  • 电话传真:
  • 电子邮箱:editorialoffice@rir-journal.com(官网邮箱)
  • 微信公众号:

审稿时间:暂无参考数据,审稿时间不确定!

投稿难度:网友分享,仅供参考

见刊周期:-

温馨提示以上只是参考信息,实际情况会根据投稿主题、稿件质量和数量、审稿流程有所差异。想获得更准确信息请联系期刊的编辑部进行咨询。

欢迎点评!让信息更透明,使投稿更轻松!
    • 审稿时间:
      是否录用:
    • 发表排期:
      查重要求:
    • 有无课题:
      有无回复:
    • 我的学历:
      我的职称:
    • 审稿费用:
      版面费用:
    • 稿       费:
      稿件字数:
    • 投稿难度:
    • 该刊可发:
    • 投稿主题:
匿名: 验证码: 点击切换验证码
    • 1、该刊只有国际刊号。

      2、投稿方式:在线投稿。

      3、官网网址:

      https://www.degruyterbrill.com/journal/key/rir/html

      4、投稿网址:http://www.editorialmanager.com/rir/

      5、官网邮箱:editorialoffice@rir-journal.com

      6、出刊日期:季刊,一年出版4期。

      2026年2月2日星期一

      《风湿病学和免疫学研究(英文)》创刊

      (Rheumatology and Immunology Research)

      【微信公众号“风湿免疫病医联体联盟”信息】

      风湿免疫病医联体联盟 2021-02-02

      在曾小峰教授的倡议和领导下,以国家皮肤与免疫疾病临床医学研究中心(NCRC-DID)为依托,创建了我国风湿病领域首个英文杂志---“Rheumatology and Immunology Research”(RIR)。

      作为 “国家皮肤与免疫疾病临床研究中心”的官方杂志,RIR的创办将为中国的风湿病与免疫疾病学者在国际舞台上发出中国的声音、为广大中国风湿病与免疫病学者搭建一个展示研究成果的平台,将成为扩大“国家皮肤与免疫疾病临床医学研究中心”的国内与国际影响、促进我国风湿病学者与免疫病学家掌握国际风湿病学与免疫学前沿与动态、聚焦学科发展、展现领域发展趋势,助力中国风湿病与免疫学家走向世界,提高全球影响力的重要载体。

      RIR将以关注领域世界发展前沿,传播领域最新研究成果为核心,以促进转化医学研究的开展、促进风湿病与免疫疾病的学科建设为创刊宗旨,成为我国与国际风湿病和免疫疾病领域重要的交流平台。

      RIR的编委会成员具有国际代表性。编委会成员由来自中国大陆、香港、台湾地区,以及美国、欧洲和亚洲的风湿病与免疫病的国际一流专家组成;杂志还特别邀请了一位来自中国大陆和一位来自美国的统计学专家作为编委会成员,为杂志发表的研究方法的科学性把关。

      RIR期刊将本着公平、公正的学术态度,建立严格的投审稿制度,吸引高质量的国际风湿病领域研究成果,为推动我国风湿病与免疫疾病的发展做出贡献。

      RIR杂志于2019年成立筹备小组,2020年初成立编委会,2020年9月网站建设完成,2020年10月杂志第一期发布,纸质版11月印刷成册。

      RIR目前为季刊,接收稿件类型包括:Original article(include meta-analysis and systemic review)、Editorial、Review、Medical Image、Case report、Letter and correspondence。

      RIR期刊网站:

      • 网站:www.rir-journal.com

      • 投稿系统:www.editorialmanager.com/rir

      联系我们:

      • xinping.tian@cstar.org.cn

      • editorialoffice@rir-journal.com

      《风湿病学和免疫学研究(英文)》作者须知

      (Rheumatology and Immunology Research)

      【官网信息】

      RHEUMATOLOGY AND IMMUNOLOGY RESEARCH

      Author Instruction

      Thank you for choosing Rheumatology and Immunology Research (RIR) as the media to publish your work.

      The mission of RIR is to provide a platform to share the best research in clinical, basic and translational medicine with our physicians. We publish original research that can elucidate mechanisms of disease or improve clinical practice in rheumatology, immunology and related sciences. In addition, we will consider publishing Concise reports of original research, reviews, editorials, cases, images, letters and correspondence, recommendations and criteria in rheumatology and immunology that will be of interest to medical professionals.

      We aim that, with your contribution and the efforts of the editorial board, RIR will become one of the most respected and widely read medical journals in rheumatology and immunology.

      SUBMISSION GUIDELINES

      All submitted manuscripts will be submitted to a rigorous review process. The scientific novelty, importance and accuracy are evaluated at editorial, statistical and peer levels. For more details, please refer to Editorial Policy.

      Before submission

      Before submit your manuscript to RIR, you need to understand the journal, gain familiarity with the scope of topics and types of articles published by RIR.

      l About the journal

      RIR is the official journal of National Clinical Research Center for Dermatological and Rheumatologic Diseases of China (NCRC-DRD). It is committed to publish scientific work related to rheumatology and immunology from a global perspective,particularly from China and the Asia-Pacific area.

      RIR is a peer reviewed, open-access scientific journal that focus on rheumatology and immunology aspects of clinical practice and the development of basic science. All papers will be published both online and in print. we aim to spread and teach new concepts, progress and changes in rheumatological and immunological aspects of clinical practice and basic science among health care professionals, so changes and improvement of clinical practice will finally benefit our patients.

      l Scope of publications

      The topics covered by RIR include rheumatological and immunological aspects of clinical practice, basic science and translational science of biomedicine.

      l Types of articles

      Original research, Concise report of Original research, Reviews, Editorials, Cases, Images, Letters and Correspondence, Commentary, Recommendations and Criteria.

      Preparation of manuscripts for submission

      It is important that to prepare your manuscript appropriately before submission. The requirement varies according to the type of article submitted. These include cover letter, title page, main text, tables and figures, supplement data and images. A cover letter is optional, but can help the editorial team in their assessment.

      Cover letter

      Although optional, a cover letter can provide more information to the editor about why the study is conducted and how it was designed, as well as convey the main results and, especially, suggest what the potential impact and novelty may be. The type of manuscript should be noted. In the cover letter, a sentence must state that the manuscript or part of the manuscript has not been submitted to or be currently under consideration by another journal. The cover letter should be concise and only contain the important information about the manuscript.

      Title page

      The title page includes:

      · Manuscript title: The title should be concise and include the important information of the contents. The maximum word is 20

      · Authors names: Complete given name and surname of all authors should be listed including their degrees (not more than 2 in total if have more), affiliation/ institution. If 2 authors contributed equally to the work, they can be co-first-author. The authors should declare that “Drs. AAA and BBB contributed equally to this work. For Corresponding author, the name and contact information including address, telephone number and email address should be included.

      Authorship

      All authors listed in the manuscript must be fully qualified for authorship and take responsibility for the contents of the manuscript. A qualified author must meet ALL of the four following criteria:

      · Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND

      · Drafting the work or revising it critically for important intellectual content; AND

      · Final approval of the version to be published; AND

      · Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. For studies that involve multi-center group, the group name may be included in the list of authors. Individual author in the group could be listed in the “Acknowledgement” section.

      Those who have helped in the design and composition of the manuscript but do not meet the criteria for authorship, should be listed in the “Acknowledgement” section.

      · Declarations

      For each manuscript, declarations including disclosure of interest conflict and ethnical statement should be included if applicable.

      Conflict of interestAuthors listed in the research articles, reviews and editorials must disclose any relationship that could be viewed as potential conflict of interest when the manuscript is submitted. The form of declaration must be submitted at the time of manuscript

      submission.

      Ethical statement

      Authors should state the approval of the study by their institution’s ethics review board (IRB) and cite the identification number of the IRB in the manuscript if applicable. For manuscripts involving human subjects, the research must comply with the Declaration of Helsinki. For manuscripts involving animal subjects, the research must be conducted in compliance with the local or national institutional review boards.

      For manuscripts that use patient related data, authors must state in a sentence that they have obtained the patients’ written informed consent form for participation in the study and for publication of their data. The consent forms must be scanned and submitted with the manuscript.

      RIR reserves the right to reject manuscripts that are considered ethically inappropriate according to the editorial committee.

      Informed consent

      For personally identifiable images that cannot be completely de-identified, authors must submit informed consent to publish from the patient.

      Funding or financial support

      Any funding or financial support related to work reported in the present manuscript should be stated. The full official name of the funding agency should be given. Please include the grant number if applicable. Other benefits from commercial sources should also be indicated.

      Main text of the manuscript

      This is the main body of the manuscript. The components and format of the main text varies according to the types of the articles.

      For original research article

      Original research reports original unpublished research on clinical, basic research and translational research in rheumatology and immunology. Systematic reviews and metaanalyses are also considered as original research.

      An original research article should include the following components:

      · Cover letter (optional)

      · Title page

      · Abstract: maximum word count: 300

      · Keywords: less than 5

      · Main body of the article: maximum word count:4500

      · Acknowledgement (if applicable)

      · References: maximum of 50

      · Tables and Figures: maximum of 6, combined

      · Supplement/appendix

      Abstract

      The abstract is subdivided into: Objectives, Methods, Results, Conclusions. The maximum word count is 300.

      ……

      更多详情:

      https://sciendo-parsed-data-feed.s3.eu-central-1.amazonaws.com/RIR/Instruction_for_Authors.pdf



    验证码: 点击切换验证码